Government Schemes 22 September 2026 · Event date: 21 September 2026

Sowa-Rigpa Working Group Holds First Meeting Under PCIM&H

Sowa-Rigpa Working Group Holds First Meeting Under PCIM&H
Official visual from the source release · Source: Press Information Bureau

The Pharmacopoeia Commission for Indian Medicine Homoeopathy hosted the first meeting of the Sowa-Rigpa Working Group in Ghaziabad, Uttar Pradesh. Chaired by Dr. Kousthubha Upadhyaya, the meeting focused on developing Sowa-Rigpa Pharmacopoeias, Formularies, and quality assurance standards under the Drugs and Cosmetics Act, 1940. This initiative aims to standardise traditional medicines within the Indian government's regulatory framework.

Why It Matters

This is relevant for exam candidates as it highlights institutional developments in traditional medicine regulation under the Ministry of Ayush.

UPSCSSCState PSC

In Simple Words

The Sowa-Rigpa Working Group held its very first meeting on September 18 at PCIM&H in Ghaziabad, Uttar Pradesh, chaired by Dr. Kousthubha Upadhyaya. The meeting marks a key development in creating official Pharmacopoeias and Formularies for the Sowa-Rigpa system of medicine in India.

Experts discussed a step-wise action plan to support regulatory provisions, quality assurance, and standardisation of Sowa-Rigpa drugs under the Drugs and Cosmetics Act, 1940. The PCIM&H, operating under the Ministry of Ayush, will oversee this work to ensure proper quality standards for traditional medicines.

Key Points

  • The first meeting of the Sowa-Rigpa Working Group was held on September 18.
  • The meeting took place at PCIM&H in Ghaziabad, Uttar Pradesh.
  • Dr. Kousthubha Upadhyaya, Director of PCIM&H, chaired the meeting.
  • Sowa-Rigpa was represented by four experts including Dr. Padma Gurmet, Director of the National Institute of Sowa-Rigpa, Leh.
  • The Working Group will develop Pharmacopoeias, Formularies, and statutory and non-statutory documents.
  • The initiative follows the Drugs and Cosmetics Act, 1940 and its Rules.
  • PCIM&H is a subordinate office under the Ministry of Ayush.
  • PCIM&H functions as the Central Drug Testing-cum-Appellate Laboratory for Indian Systems of Medicine and Homoeopathy.

Exam Angle

Ministry
Ministry of Ayush
Location of meeting
PCIM&H, Ghaziabad, Uttar Pradesh
Chairperson
Dr. Kousthubha Upadhyaya
Governing Act
Drugs and Cosmetics Act, 1940

A. Dr. Kousthubha Upadhyaya, Director, PCIM&H

Related Current Affairs

Daily Current Affairs Digest — 5 November 2026 The Daily Digest for 5 November 2026 covers major national policy milestones including the Bharat Renewable Energy Summit 2026 where India reinforced its clean energy commitment, strategic Indo-Pacific maritime dialogues like IPRD-2026, and stellar economic indicators reflecting nearly 100 Mt in finished steel consumption. International updates capture key diplomatic milestones such as India's leadership in the Kimberley Process and defence engagements like Exercise Malabar 2026 in Japan. Daily Current Affairs Digest — 4 November 2026 Today's comprehensive digest covers major policy developments including the Union Cabinet's approval of a ₹14,500 crore Viability Gap Funding scheme for grid-scale energy storage systems, findings from the Annual Survey of Industries 2024-25, and international updates from the US Midterm Elections 2026. Important milestones include the NLMC's RINL land auction in Visakhapatnam and the release of India's I-OECM guidelines at CBD COP-17 in Armenia. Daily Current Affairs Digest — 3 November 2026 This comprehensive daily digest for 3 November 2026 covers major national and international developments, including India's renewable energy push at the BRE Summit, strategic defence dialogues like IPRD-2026 in New Delhi, and important economic updates such as APEDA facilitating pomegranates export to Dubai. Key multilateral engagements include the India-US Tiger Triumph 2026 exercise and the India-Sri Lanka Coast Guard high-level meeting in Mirissa. Daily Current Affairs Digest — 2 November 2026 Prime Minister Narendra Modi inaugurated the Bharat Renewable Energy Summit & Expo 2026 in New Delhi, emphasizing renewable energy's critical role amid global energy shocks. In a major defence boost under Aatmanirbhar Bharat, the Ministry of Defence signed ₹53,866.50 crore contracts with GRSE and GSL for eight Next Generation Corvettes for the Indian Navy. Meanwhile, Western Coalfields Limited (WCL) emerged as a top growth engine for Coal India, and key government ministries successfully concluded Special Campaign 6 focusing on cleanliness, e-waste management, and administrative efficiency.